The United Kingdom has legalized medical cannabis since November 2018, but its access and understanding are patchy. Initially, it was restricted to a few conditions, but the number of patients who can be treated with cannabis-based medicinal products has been increasing over time.
Recent statistics indicate a steep increase in the imports of medical cannabis, with more than 23,000 kilograms being imported in 2023 – over three times the amount imported the previous year. This trend indicates that there is further acceptance of medical cannabis as treatment, as well as growing demand.
Despite the growing usage and its legal status, awareness regarding medical cannabis remains relatively low. Almost 60% of the respondents in a recent national survey were not sure whether medical cannabis is legal in the UK.
Even more startling is that less than one percent of potential beneficiaries actively seek a prescription. These statistics tell of a larger problem: While there is an enabling policy framework containing legal access provisions, prospective patients do not know how to access the information that enables them to utilize these provisions.
The National Health Service (NHS) is currently practicing a very restricted approach with regard to access to cannabis-based medicines. The majority of NHS prescriptions revolve around a few specific, refractorily treatable conditions, like rare forms of epilepsy in children. Subsequently, the vast majority of people in the country resort to private practitioners to assess this therapeutic option.
Conditions Commonly Treated with Medical Cannabis
A wide range of health issues are now being considered for medical cannabis prescriptions, more so in instances where there is insufficient relief from conventional treatment modalities. Chronic pain remains consistently one of the most commonly reported reasons for seeking medical cannabis, with patients suffering from arthritis, fibromyalgia, migraine, and back pain being the most common.
Neurosurgical issues like multiple sclerosis, epilepsy, and even Parkinson’s disease have also been found to rank high in the list of medically treated conditions.
An emerging area where patients have sought medical cannabis is mental health conditions like anxiety and post-traumatic stress disorder (PTSD). Though this use does undergo a strict triage system.
Patients must unarguably demonstrate that conventional therapies have been attempted and failed or elicited unbearable side effects. A private cannabis clinic usually involves some form of stepwise procedure, starting from an initial screening session followed by several layers of requisite documentation from a GP or specialist.
The interest in cannabis treatments has also increased for women’s health issues such as endometriosis and premenstrual dysphoric disorder (PMDD). Likewise, patients suffering from gastrointestinal issues like Crohn’s disease or irritable bowel syndrome (IBS) are starting to research the benefits of medical cannabis for symptom relief, particularly for abdominal pain and inflammation.
It must be emphasized that prescriptions are not given casually. Clinics have strict clinical guidelines to follow, and only those who qualify can progress to treatment. This is done to maintain the credibility of cannabis as a treatment option within the UK medical framework.
The projection for medical cannabis usage shows a steep increase in the coming years, with patients expected to grow exponentially. It is estimated that over 70,000 people will qualify for medical cannabis, and this number could reach 160,000 by the end of 2025. This growth heavily depends on whether general practitioners start prescribing cannabis-based treatments more freely. Currently, prescriptions are primarily written at private clinics, which poses a financial challenge for many patients.
An example of the approach focused on enhancing access and affordability is the cultivation of cannabis within the country. Licensed growing facilities within the UK have been set up, which can grow and process hundreds of kilograms of medical-grade cannabis every month.
These operations are intended to curtail international imports and establish a reliable and cost-efficient supply chain. It has been reported that some of these facilities can meet the demand of thousands of monthly prescriptions, suggesting a shift towards self-sufficiency.
Nevertheless, some hurdles still need to be overcome. Along with some of these barriers being regulatory, there are also educational or social barriers. Stigmatization, lack of proper information, and misunderstanding create barriers in the perception of medical cannabis. Moreover, the existence of an unregulated market presents a danger alongside the burgeoning legal one.
A study recently conducted discovered the presence of mold, lead, and bacteria as contaminants in cannabis purchased off the streets. These results highlight the need to seek medical treatment through controlled and credible medical frameworks.
The Future of Medical Cannabis in the UK
The medical field is bound to witness a drastic transformation in the very near future. The more studies that get published regarding the effectiveness and safety of using cannabis in the development of medicines, the easier it will become for healthcare professionals to accept and discuss its prescription. While this may take a long time, the incorporation of cannabis into healthcare will be more seamless.
A few key points can be made concerning medical cannabis in the UK. Demand is increasing, new facilities are being built, and societal views are softening. However, there is still a significant lack of information that creates problems along with the access being available mostly through private medical funding. Regulations, public understanding, and professional involvement require further advances before medical cannabis can be adequately integrated into a patient’s routine care.
This refinement process is critical for the treatment to not only be available at a basic level in the UK healthcare system, but also be positioned as a commonly used treatment method.